As of Sep 27
| +0.47 / +1.73%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 31.50, with a high estimate of 35.00 and a low estimate of 22.00. The median estimate represents a +13.88% increase from the last price of 27.66.
The current consensus among 8 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.